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Objective: We investigated quantitative electroencephalography (qEEG) and clinical
parameters as potential risk factors of severe cognitive decline in Parkinson’s disease.
Methods: We prospectively investigated 37 patients with Parkinson’s disease at
baseline and follow-up (after 3 years). Patients had no severe cognitive impairment
at baseline. We used a summary score of cognitive tests as the outcome at follow-
up. At baseline we assessed motor, cognitive, and psychiatric factors; qEEG variables
[global relative median power (GRMP) spectra] were obtained by a fully automated
processing of high-resolution EEG (256-channels). We used linear regression models
with calculation of the explained variance to evaluate the relation of baseline parameters
with cognitive deterioration.
Results: The following baseline parameters significantly predicted severe cognitive
decline: GRMP theta (4–8 Hz), cognitive task performance in executive functions and
working memory.
Conclusions: Combination of neurocognitive tests and qEEG improves identification of
patients with higher risk of cognitive decline in PD.
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INTRODUCTION
The progression of Parkinson’s disease (PD) is associated with cognitive decline and dementia
(Aarsland et al., 2005; Goldman et al., 2012). Dementia in PD reaches about 30% of all cases with
PD (Emre, 2003). The risk of dementia is about 80% for the patients living for more than 20 years
with PD (Hely et al., 2008). Early and correct identification of the patients with the risk of severe
cognitive decline is a challenging problem of neurology, which has led to the suggestion of various
markers of cognitive decline in PD (Mollenhauer et al., 2014). Quantitative electroencephalography
(qEEG) – digital processing of EEG recordings to obtain numerical and graphical data – showed
that the power (the square of amplitudes of electrical activity) of the brain in PD patients with
cognitive impairment is increased in the frequency range below 8 Hz, and decreased in the range
above 8 Hz (Caviness et al., 2007; Fonseca et al., 2009; Babiloni et al., 2011). Additionally, in cohort
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studies qEEG produced promising results in predicting
progression to dementia in PD (Bonanni et al., 2008; Klassen
et al., 2011; Gu et al., 2014; Olde Dubbelink et al., 2014).
The purpose of our study was to investigate clinical and
qEEG parameters as predictors of severe cognitive decline in
PD, using high-resolution EEG with 256 electrodes and with
fully automated removal of artifacts (Hatz et al., 2015). Our
hypothesis was that qEEG variables at baseline are able to
predict severe cognitive decline, and these qEEG variables are not
influenced by clinical and demographic parameters. To address
this research question a prospective (3 years) cohort of PD
patients was assessed for potential neurological, psychological,
and neurophysiological risk factors.
MATERIALS AND METHODS
Enrollment of the Patients
Patients were recruited from the outpatient clinic of the
Department of Neurology and Neurophysiology of the Hospital
of the University of Basel (City of Basel, Switzerland) in the
period from 2011 to 2012. Selection criteria: PD according
to United Kingdom Parkinson’s Disease Society Brain Bank
criteria (Gibb and Lees, 1988). The patients who had dementia
(Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition), history of stroke, epilepsy, multiple sclerosis and
surgical interventions to the brain, or/and insufficient knowledge
of German language, were excluded. Included patients underwent
neurological, cognitive and qEEG examinations on inclusion
(baseline) and after a mean interval of 3 years (follow-up).
Specialists who performed the assessment of the patients
(neurologists, neuropsychologists, and technicians) were
unaware of the details of this study.
Standard Protocol Approvals,
Registrations, and Patient Consents
The research ethics committee of the Cantons of Basel
(Ethikkommission beider Basel) approved this study. All patients
were fully informed of the nature of the study and provided
written consent to participate.
Neurological Assessment
Subsection III (motor examination) of the Unified Parkinson’s
Disease Rating Scale (UPDRS-III) was filled out. Levodopa
equivalent of the daily dose of the antiparkinsonian medication
was calculated (LEDD, Tomlinson et al., 2010). Disease duration
was assessed since the first symptoms of PD reported by the
patient or caregiver.
Cognitive Assessment
Cognitive evaluation was performed in individual sessions
divided in three parts; each part with duration of approximately
90 min per day. The interval between the parts of each session
was between 24 and 48 h. Mini-Mental State Examination and
a battery of 14 cognitive tests were applied. Test variables
were normalized with reference to a normative data base of
604 healthy controls from the Memory Clinic, Felix Platter
Hospital of Basel, Switzerland (Berres et al., 2000). Cognitive
tests were grouped in six cognitive domains (Zimmermann
et al., 2015): “attention,” “executive functions,” “fluency,” “long-
term memory,” “working memory,” and “visual-spatial functions”
(Table 1). A score reflecting cognitive performance in each
domain comprised mean of the constituent test variables.
Additionally, an overall cognitive score comprised a mean of all
14 cognitive tests. Mood and behavior were assessed with tests:
Beck Depression Inventory-II, and compartment “Emotional
well-being” (six items with five-step gradation) of the Parkinson’s
disease Questionnaire with 39 items.
Neurophysiological Assessment
Continuous EEG with 256 electrodes (214 active electrodes)
was recorded in relaxed eyes-closed state of the patients (Net
Station 300; Electrical Geodesics, Inc). Electrode located at CZ
was used as reference. The sampling rate was set at 1000 Hz,
oscillations were filtered with 2500 order least-square filter
with band-pass 0.5–70 Hz, and notch 50 Hz. Spectral analysis
was performed with “TAPEEG” toolbox (Hatz et al., 2015) by
multitaper method (Percival and Walden, 1993). Detection and
removal of artifacts (e.g., eye blinks) was fully automated, by an
independent component analysis. Channels with bad activations
were automatically detected and interpolated by spherical spline
method. Global relative median power (GRMP) was calculated
in frequency ranges: delta (1–4 Hz), theta (4–8 Hz), alpha1 (8–
10 Hz), alpha2 (10–13 Hz), and beta (13–30 Hz). Additionally,
median value in the frequency range 4–14 Hz was calculated as
the 50% quantile of the overall power spectrum from occipital
electrodes – occipital median frequency (Figure 1).
Statistics
Statistical calculations were performed with R tool for statistical
calculations (R Core Team, 2015). The normality of the
distribution of the data was tested with Shapiro–Wilk test. The
TABLE 1 | Cognitive tests and cognitive domains.
Domain Tests within a domain
(1) Attention • Stroop Color-Word: time for color naming
• Trail-Making: time for part A
• Digit Span: correct backward
(2) Executive functions • Trail-Making: time for part B divided by time
for part A
• Stroop Color-Word: time for interference task
divided by time for color naming
• Wisconsin Card Sorting: number of errors
(3) Fluency • Phonemic verbal fluency: correct answers
• Semantic verbal fluency: correct answers
(4) Long-term memory • Verbal Learning – long-delayed recall
• Verbal Learning – discrimination
(5) Working memory • Corsi blocks: correct forward
• Divided attention: omissions
(6) Visual-spatial functions • Block design
• Rey-Osterrieth complex figure copy
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FIGURE 1 | Electrode mapping of 256 electrodes. Active electrodes colored in dark and light green, occipital electrodes – dark green.
influence of the baseline parameters on cognitive state at follow-
up was checked with univariate and multivariate linear regression
models with backward elimination. Prediction accuracy was
checked with receiver operating characteristic (ROC) curves. The
results were additionally checked with Random Forest method
with regression. The level of statistical significance was set
at 0.05.
Cognitive Outcome
A change index in overall cognitive score (CI-OCS) was used
as outcome. The CI-OCS was calculated as difference in overall
cognitive score between follow-up and baseline, divided by the
standard error of the difference (Jacobson and Truax, 1991).
Regression Models
The following baseline variables were considered as predictors:
GRMP in ranges delta, theta, alpha1, alpha2, and beta, MF,
cognitive domains: “attention,” “executive functions,” “fluency,”
“long-term memory,” “working memory,” and “visual-spatial
functions,” age, sex, highest educational level (measured in
years), disease duration (years), duration of observation (years),
LEDD, and UPDRS-III. Significant variables from the univariate
regression models were included in multivariate models. To
check the added value of the significant predictors to the
cognitive task performance, non-normalized to 100% explained
variance of the models was calculated. The relative importance
of the variables was calculated with the R package “relaimpo”
(Grömping, 2006) with method “LMG” and plotted in a bar
diagram.
ROC-Curves
The ROC-curve analyses were performed with the R package
“pROC” (Robin et al., 2011). We categorized the sample on the
basis of MMSE score at follow-up (cut off<24).
Random Forest with Regression
Random Forest (Hastie et al., 2009) is an ensemble machine
learning method used for classifying data with high accuracy and
for regression analysis. The goal of this method is to reduce the
variance in the data and get a higher predictive performance
of the model. This is done by using several decision trees,
which are constructed based on subsets of the same training
data, and then getting predictions on the test set based on
the training. Each variable included in the model is evaluated
based on its effect on the overall accuracy of the model and
is ranked higher up if its exclusion results in a drop in the
model accuracy. The role of each variable in the classification
process is reflected in output measures called mean decrease
accuracy (MDA) and mean decrease gini coefficient (MDGC).
MDA is the increase in mean squared error of predictions
after predictor variables being randomly shuﬄed. Higher the
MDA, the more important is the variable. MDGC relates to
the decrease of node impurity in the decision tree after each
split, summed over all splits and trees. Higher the MDGC
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is, the more important the variable. Random Forest analysis
was performed with the R package “randomForest” (Liaw and
Wiener, 2002).
RESULTS
Enrollment of the Patients
Between January 2012 and December 2013, 55 patients were
selected in the study and assessed for neurological, psychological
and qEEG parameters (Supplement 1). At follow-up, cognitive
outcome along with the other clinical data was obtained for 37
patients. Thus, these 37 patients were included in the analysis
(Table 2). Changes in neurological and cognitive features of the
sample are shown in Supplement 2.
Influence on CI-OCS
Regression analyses (Supplement 3, Tables 3–6) identified three
baseline parameters which had significant influence on CI-OCS:
GRMP theta (β=−3.16, p< 0.001), cognitive domain “executive
functions” (β = 0.54, p < 0.001), cognitive domain “working
memory” (β = 0.19, p < 0.05), adjusted R squared = 0.64,
p < 0.001. Explained variance of the overall model was 66.9%, of
which “executive functions” made 27.5%, GRMP theta – 25.8%,
and “working memory” – 13.6% (Supplement 3, Table 6).
TABLE 2 | Sample at baseline.
Factors Values
Sex, males/females 25/12
Age, years 67 [31, 84]
Disease duration, years 8 [1, 20]
Duration of observation, months 37 [30, 44]
Education, years 14 [9, 20]
Beck Depression Inventory-II 6 [0, 15]
Obsessive Compulsive Inventory 6 [0, 25]
PDQ39 – emotional well-being 17 [0, 50]
UPDRS, Subscale III 14 [0, 50]
Levodopa equivalent, mg per day 691 [150, 2129]
Attention −0.02 [−2.07, 1.13]
Executive functions −0.03 [−3.73, 1.17]
Fluency −0.18 [−1.93, 1.61]
Long-term memory −0.13 [−1.62, 2.60]
Working memory −0.23 [−1.50, 2.37]
Visual-spatial functions −0.23 [−2.60, 1.79]
Overall cognitive score −0.10 [−2.05, 0.96]
Mini Mental State 29 [24, 30]
GRMP delta, % 22 [9, 42]
GRMP theta, % 18 [10, 46]
GRMP alpha1, % 18 [5, 33]
GRMP alpha2, % 13 [5, 33]
GRMP beta, % 20 [10, 38]
Median frequency, Hz 8.71 [7.14, 9.99]
For continuous variables presented as median and range (M [min, max]). GRMP,
global relative median power; PDQ39, Parkinson’s disease questionnaire with 39
items; UPDRS, unified Parkinson’s disease rating scale.
Additionally, we checked if age, sex, and education had
confounding effect on each of the three significant variables
(GRMP theta, “executive functions,” and “working memory”). No
confounding effects were identified (Figure 2).
ROC-Curve Analyses
Receiver operating characteristic were built using variables:
GRMP theta, “executive functions,” and “working memory.”
Best accuracy was identified in GRMP theta: AUC = 75%,
specificity = 63%, specificity = 77% (Figure 3; Supplement 3,
Table 7).
Random Forest
Global relative median power theta was classified as the most
important variable (MDA = 7.49, MDGC = 1.63) (Supplement
3, Table 8).
DISCUSSION
In our observation, increase of GRMP theta (4–8 Hz), and
decrease of cognitive performance in domains “executive
functions” and “working memory” significantly predicted worse
CI-OCS after 3 years.
Our findings in GRMP theta are in line with the data from
cohort studies with semi-automated processing of EEG (Klassen
et al., 2011; Olde Dubbelink et al., 2014). Additionally, in
cross-sectional comparisons between Parkinson’s disease patients
with dementia and matched healthy controls, spectral power in
the frequency range below 8 Hz was significantly increased in
demented patients (Babiloni et al., 2011; Fonseca et al., 2013).
From a pathophysiologic perspective, EEG slowing in severe
cognitive decline may be explained by disruption of thalamo-
cortical circuits, and pathological synchronization of the brain
motor systems with slow frequencies related to the sensory
motor integration (Steriade et al., 1990; Rossini et al., 1991). We
can speculate that these pathological changes precede clinical
manifestation of cognitive decline in PD.
With regard to cognitive factors, we found that worse scores
in domains “executive functions” and “working memory” are
significant predictors of cognitive decline. Zimmermann et al.
(2015) in a cross-sectional analysis showed significant correlation
of occipital median frequency with overall cognitive score,
domains “executive functions,” “long-term memory,” “attention,”
and “fluency” in dementia-free patients with PD. Olde Dubbelink
et al. (2014) found that fronto-executive (spatial span score) and
posterior (pattern recognition memory) significantly predicted
dementia in Parkinson’s disease. Impairment of the executive
functions is common in the early stage of PD (Kehagia et al.,
2010). However, the cognitive profile of early stage PD is
heterogeneous, and the significance of domain-specific cognitive
deficits in identifying patients with a risk of dementia is still
studied (Robbins and Cools, 2014).
Our findings demonstrate that a combination of
neurocognitive tests with qEEG improves identification of
patients with PD and higher risk of cognitive decline. While
it is important for practical reasons to identify strong risk
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FIGURE 2 | Results of the linear regression analyses. Confounding effect of age, male sex, and education on the significant predictors of cognitive decline
(GMRP theta, executive functions, and working memory). The variance of the models, that is explained by these predictors, is shown.
FIGURE 3 | Receiver operating characteristic (ROC)-curves analyses.
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factors for dementia developing within 1 or 2 years, the short
mean observation period of 3 years is a limitation of the study,
and a longer follow-up is warranted. Another limitation is the
relatively small sample size. Strengths of the study include the
comprehensive neuropsychological and psychiatric assessments
as well as the fully automated processing of high-resolution EEG,
which could be implemented in clinical practice as a universally
available technique. Additionally, automated processing of EEG
facilitates the application of advanced analyses of the cognitive
function.
CONCLUSION
High GRMP theta, especially when combined with poorer
cognitive scores in “executive functions” and “working memory,”
identifies patients with PD who are at a higher risk of progression
to dementia.
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